DD108760A1 - - Google Patents

Info

Publication number
DD108760A1
DD108760A1 DD17437373A DD17437373A DD108760A1 DD 108760 A1 DD108760 A1 DD 108760A1 DD 17437373 A DD17437373 A DD 17437373A DD 17437373 A DD17437373 A DD 17437373A DD 108760 A1 DD108760 A1 DD 108760A1
Authority
DD
German Democratic Republic
Application number
DD17437373A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to DD17437373A priority Critical patent/DD108760A1/xx
Publication of DD108760A1 publication Critical patent/DD108760A1/xx

Links

DD17437373A 1973-11-02 1973-11-02 DD108760A1 (https=)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DD17437373A DD108760A1 (https=) 1973-11-02 1973-11-02

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DD17437373A DD108760A1 (https=) 1973-11-02 1973-11-02

Publications (1)

Publication Number Publication Date
DD108760A1 true DD108760A1 (https=) 1974-10-05

Family

ID=5493286

Family Applications (1)

Application Number Title Priority Date Filing Date
DD17437373A DD108760A1 (https=) 1973-11-02 1973-11-02

Country Status (1)

Country Link
DD (1) DD108760A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1840145A1 (en) 2006-03-30 2007-10-03 GAT Microencapsulation AG Acetylene carbamide derivatives-polyurea polymers and microcapsules and formulations thereof for controlled release
WO2007112933A1 (en) * 2006-03-30 2007-10-11 Gat Microencapsulation Ag Reverse-phase microcapsules for active ingredients, simplified process of manufacture thereof and combined formulations wdg-cs, zc, ec-sc and cx

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1840145A1 (en) 2006-03-30 2007-10-03 GAT Microencapsulation AG Acetylene carbamide derivatives-polyurea polymers and microcapsules and formulations thereof for controlled release
WO2007112934A1 (en) * 2006-03-30 2007-10-11 Gat Microencapsulation Ag Microcapsules with acetylene carbamide-polyurea polymers and formulations thereof for controlled release
WO2007112933A1 (en) * 2006-03-30 2007-10-11 Gat Microencapsulation Ag Reverse-phase microcapsules for active ingredients, simplified process of manufacture thereof and combined formulations wdg-cs, zc, ec-sc and cx
US8216598B2 (en) 2006-03-30 2012-07-10 Gat Microencapsulation Ag Microcapsules with acetylene carbamide-polyurea polymers and formulations thereof for controlled release
EP2487192A3 (en) * 2006-03-30 2012-09-05 Gat Microencapsulation, AG Microencapsulation of clomazone by means of a refined process and specific microcapsules produced thereof
US8337900B2 (en) 2006-03-30 2012-12-25 Casanginer Victor Reverse-phase microcapsules for active ingredients, simplified process of manufacture thereof and combined formulation WDG-CS, ZC, EC-SC, and CX
EP1840145B1 (en) 2006-03-30 2017-11-08 FMC Corporation Acetylene carbamide derivatives-polyurea polymers and microcapsules and formulations thereof for controlled release
EP2487192B1 (en) 2006-03-30 2021-03-03 FMC Corporation Microencapsulation of clomazone by means of a refined process and specific microcapsules produced thereof

Similar Documents

Publication Publication Date Title
AU476761B2 (https=)
AU465372B2 (https=)
AU474593B2 (https=)
AU474511B2 (https=)
AU474838B2 (https=)
AU471343B2 (https=)
AU465453B2 (https=)
AU465434B2 (https=)
AU450229B2 (https=)
AU476714B2 (https=)
AU472848B2 (https=)
AU466283B2 (https=)
AU476696B2 (https=)
AU477823B2 (https=)
AU471461B2 (https=)
AU461342B2 (https=)
AU476873B1 (https=)
AU477824B2 (https=)
AU1891376A (https=)
CH560514A5 (https=)
DD108760A1 (https=)
AU479522A (https=)
AU479504A (https=)
AU479496A (https=)
AU479458A (https=)